Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5415_Библиотеки_им_академика_М_И_Перельмана
.pdf
234
https://t.me/medicina_free
Index
N
Nasal pressurized metered dose inhaler, 219
Nasal spray pump, 219
Nebulizers, 197, 201–204
Negative heat of solution, 95
New drug application (NDA), 19, 20
New molecular entity, 20, 88
Newtonian ow, 114, 115
Non-Newtonian ow, 114, 115
Nonpareils, 78, 82
Noyes-Whitney equation, 29, 95, 96
O
Oil-in-water (O/W) emulsion, 125, 132–138,
140, 160–162
Ointment, 142, 146, 147, 149, 160–162, 167,
176, 184
Oleaginous, 132, 161, 162, 188–190, 192
One-compartment model, 16
Opacier, 58, 59
Ophthalmic delivery, 142, 147
Ophthalmic emulsions, 147
Ophthalmic gels, 147
Ophthalmic ointments, 146, 147
Ophthalmic solutions, 146, 227
Ophthalmic suspensions, 146
Orally inhaled drug products, 196
Oral mucosa, 53, 172–177
Orange Book, 5, 7, 8, 20, 229
Orange peel (tablet coating), 56, 63
Organogel, 162
Osmotic pump systems, 78, 83, 85
Ostwald ripening, 116–118, 121, 207
Otic delivery, 142
Oxidation, 41–43, 80, 98, 99, 165, 189, 192
P
Paracellular permeation, 173
Parenteral drug delivery, 101
Partially miscible, 95
Partition coefcient, 6, 26, 29–31, 81, 155,
159, 188
Passive dry powder inhalers, 209, 210
Paste, 118, 160
Peel adhesion, 163
Peeling (tablet coating), 56, 64
Pegylation, 223
Percutaneous absorption, 153, 157, 158, 166
Periocular administration, 142
Peripheral compartment, 16
Permeation enhancer, 156, 158, 167
Pharmacokinetics, 14–17, 20, 25, 77, 229
Phase inversion, 140
Phase transitions, 36
pH-dependent enteric coating, 75, 76
Phlebitis, 103
Photolysis, 42
Physical stability, 33–35, 40, 44, 51, 116,
125, 229
Physicochemical properties, 6, 7, 10, 14, 25,
26, 35, 70, 93, 94, 105, 156, 172,
183, 217, 223
Picking (tablet coating), 56, 62
pKa, 6, 28–29, 34, 94, 95, 173
Plasticizer, 50, 51, 56, 58, 59, 69, 82, 84,
165, 177
Plastic or interfacial lm theory, 135
Polyacrylate copolymers, 164, 165
Polyisobutylenes (PIBs), 164, 165
Polymer, 33, 34, 43, 49–51, 56, 58, 59, 67–69,
75, 76, 79–84, 95, 104, 115, 116,
121, 123, 125–127, 133, 137, 147,
158, 159, 163–166, 176, 177, 184,
186, 187, 217
Polymeric emulsiers, 125, 126, 136
Polymorph, 35–37, 40, 66, 117, 188, 189
Polysiloxanes, 158, 164, 165
Porogen, 81, 82, 84
Positive heat of solution, 95
Pre-class reading assignment, 2
Preformulation studies, 25–40, 45–46,
59, 94, 95
Preservatives, 97–99, 101, 102, 105, 122, 127,
138, 144, 145, 163, 168, 208,
217, 218
Pressurized metered dose inhalers, 197,
198, 204
Priming, 205, 219
Prodrug, 45, 88
Prolonged release, 77
Protective layer, 164
Pulsatile release systems, 86
Purple Book, 8, 229
Push-pull system, 83
Pyrogens, 101, 105, 106, 228
R
Relative bioavailability, 18
Relative humidity (RH), 43, 44
Relative solubility, 94
Reservoir system (vaginal rings), 186
Reservoir-type patch, 164
Respirable fraction (RF), 213

Index
https://t.me/medicina_free
235
Respiratory airway, 198
Rheology, 114–115
Roller compaction, 55, 60
S
Salting-in, 95
Salting-out, 95
Saturated solution, 26, 93, 155
Scintigraphic studies, 212
Sedimentation (particle deposition), 116,
199, 200
Shear rate, 114, 115
Shear strength, 163
Shear stress, 114, 115
Shear-thickening/dilatant ow, 115
Shear-thinning/pseudoplastic ow, 115
Sieve, 55
Sink condition, 155
Slug, 55
Small-volume parenterals, 107
Solid dispersions, 66–70
Solubility, 6, 18, 26–29, 32–35, 39, 40, 45, 51,
53, 66, 69, 71, 75, 77, 80–82, 87,
93–96, 99, 100, 103, 111, 117, 121,
122, 125, 126, 132, 144, 146, 147,
149, 158, 159, 163, 165, 173, 187,
190, 199, 207, 208, 217
Solution based dosage forms, 93–107
Solvate/pseudopolymorph, 35
Solvents, 27, 29, 30, 32, 34, 35, 37, 40, 41, 51,
54, 56, 64, 67, 70, 71, 82, 84, 87,
93–98, 101, 102, 104, 111, 124,
158, 162, 164, 165, 204, 224
Solvent casting method, 165
Sonophoresis, 159
Spacers, 207
Spray drying, 34, 67, 70, 71, 209
Spring and parachute, 67–69
Stereoisomer, 44–46
Steric stabilization, 117, 125, 136
Sterilization, 8, 105–106, 128–129
Stokes-Einstein equation, 120
Stratum corneum, 153–156, 158, 159, 165
Structured vehicle, 116
Subconjunctival administration, 142
Subcutaneous (SC) administration, 103
Sublimation, 104, 105
Sublingual administration, 172, 176
Supersaturated solution, 26, 69, 159
Suppositories, 30, 182, 184–194
Suprachoroidal administration, 142
Surface active agent (surfactant), 59, 99, 100,
114, 136, 147
Surface free energy, 116–117, 122, 135
Surface tension theory, 135
Surfactant, 59, 69, 82, 99–102, 111, 117–127,
132, 133, 135–138, 147, 158, 188,
190–192, 200, 204, 208, 217,
224, 229
Suspension, 27, 34, 104, 111–128, 134, 142,
146, 149, 190, 193, 201, 202, 204,
206–208, 216, 217, 219
Sustained release, 54, 59, 77, 177
Syringeability, 103–104
T
Tablet, 34, 49–71, 74, 75, 78–86, 175, 177,
178, 186, 187
Tablet ejection, 52
Tableting die, 52, 54
Tablet punch, 52
Tack, 158, 163, 165
Tapped density, 38
Team-based learning, 1, 2
Thermogravimetric analysis (TGA), 35–37
Thixotropic ow, 115
Time to maximum concentration (Tmax),
16, 17, 21
Topical drug delivery, 153
Transcellular permeation, 173
Transcellular route (passive diffusion), 155,
156, 173
Transdermal drug delivery, 153–166
Turbulent ow, 211
Two-compartment model, 16
Tyndall effect, 119
U
Ultrasonic nebulizers, 201–203
United States Pharmacopeia (USP), 8, 27, 29,
30, 32, 61, 64, 65, 76, 86–87, 93,
94, 97, 102, 106, 107, 126, 155,
160–162, 175, 178, 189, 204,
213, 224–226
V
Vibrating mesh nebulizers, 201–204
Viscoplastic ow, 115
Viscosity, 34, 40, 56, 69, 80, 82, 96, 97,
112, 114–116, 120, 122, 138,
140, 145, 149, 161, 163, 164,
167, 184, 190, 193, 201–204,
209, 219
Viscosity-enhancing agents, 122, 184,
192, 218
Volume-weighted distribution, 39

236
https://t.me/medicina_free
Index
W
Water-in-oil (W/O) emulsion, 132–138, 140,
160, 161
Water-removable base, 161, 162
Water-soluble base, 188, 193
Wet ball milling, 121
Wet granulation, 54
Wet gum method, 138
Wetting agent, 118, 123–125, 136
X
X-ray diffraction (XRD), 35, 36
Z
Zero-order release, 82, 83, 166
Zeta potential, 114–117, 127
Zwitterion, 28, 29
Соседние файлы в папке Библиотека им академика М.И. Перельмана
